SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 19.55 |
| Enterprise Value ($M) | -5.27 |
| Book Value ($M) | 13.32 |
| Book Value / Share | 1.14 |
| Price / Book | 1.47 |
| NCAV ($M) | 12.21 |
| NCAV / Share | 1.04 |
| Price / NCAV | 1.60 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.63 |
| Return on Assets (ROA) | -0.92 |
| Return on Equity (ROE) | -1.34 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.19 |
| Current Ratio | 3.19 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 34.95 |
| Assets | 36.06 |
| Liabilities | 22.73 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 3.37 |
| Operating Income | -55.16 |
| Net Income | -57.28 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -51.61 |
| Cash from Investing | 38.77 |
| Cash from Financing | 20.94 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | New Enterprise Associates 14, L.P. | 25.00 | 0.00 | |
| 13G | Radoff Bradley Louis | 5.40 | ||
| 13D | Funicular Funds, LP | 36.00 | ||
| 13G | Armistice Capital, Llc | 9.99 | ||
| 13G/A | Kryzanowski John A | 9.51 | -80.32 | |
| 13G/A | Fmr Llc | 2.81 | -60.01 | |
| 13G/A | FIL Ltd | 5.40 | ||
| 13D/A | Orbimed Advisors Llc | 4.70 | -93.33 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,210 | 1,863 | 64.95 | |
| 103 | 4,820 | 2.14 | |
| 5,464 | 31,355 | 17.43 | |
| 5,248 | 7,902 | 66.41 | |
| 201 | 6,440 | 3.12 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SRZN – Surrozen, Inc. | SXTC – China SXT Pharmaceuticals, Inc. |
| SXTP – 60 Degrees Pharmaceuticals, Inc. | TCON – TRACON Pharmaceuticals, Inc. |
| TCRT – Alaunos Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io